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Background:  Bariatric surgery (BS) has been shown to improve endothelial function in obese patients. However, whether BS improves coronary 
microvascular dilation (CMVD) is unknown.
Methods:  We studied 50 obese patients (pts, age 38±9, 13 M) who underwent BS and 18 untreated obese controls (age 41±11, 6 M). Pts had no 
evidence of cardiovascular disease. Peripheral vascular function was assessed by measuring brachial artery dilation during post-ischemic forearm 
hyperemia (flow mediated dilation, FMD) and in response to 25 μg of sublingual glyceryl trinitrate (nitrate-mediated dilation, NMD). CMVD in 
response to i.v. adenosine administration (CMVD-ADO) and to cold pressor test (CMVD-CPT) was assessed in the left anterior descending coronary 
artery by transthoracic Doppler echocardiography. CMVD-ADO was measured as the ratio of coronary blood flow velocity (CBFV) at peak ADO and at 
rest; CMVD-CPT was measured as the ratio of CBFV during CPT and at rest. The tests were repeated 3 months after intervention in the BS group and 
at 3-month follow-up in control pts.
Results:  At baseline, clinical and anthropometric variables, and FMD and CMVD were similar in the 2 groups. At follow-up a significant 
improvement in FMD and in CMVD was observed in BS pts, but not in controls (Table). NMD did not change in both groups.
Conclusions:  Our data show that, together with peripheral endothelial function, BS, in obese pts, improves CMVD; these effects might contribute 
to reduce cardiovascular risk in these pts. 
BS group Control group
Basal 3 months P Basal 3 months P
BMI (Kg/m2) 47.1±8.4 36.8±7.7 <0.01 47.2±8.0 47.3±8.3 0.70
WHR 0.92±0.09 0.87±0.11 <0.01 0.91±0.08 0.92±0.09 0.37
FMD (%) 5.9±2.7 8.8±2.4 <0.01 6.3±3.4 6.4±3.3 0.40
NMD (%) 12.7±3.2 12.8±2.3 0.73 11.4±2.4 11.5±2.4 0.63
CMVD-CPT 1.43±0.26 2.13±0.55 <0.01 1.37±0.27 1.36±0.20 0.78
CMVD-ADO 1.63±0.47 2.45±0.57 <0.01 1.55±0.40 1.57±0.38 0.88
.
